CAMPATH

ALEMTUZUMAB · Genzyme Corporation

Drug timelines are a Plus or Pro feature.

65 regulatory and trial events tracked for CAMPATH, covering 2006-05-22 to 2026-03-25. Get the full timeline:

Most recent: Clinical Trial Update: Campath/Fludarabine/Melphalan Transplant Conditioning for Non-Malignant Diseases [Phase 1, Phase 2]